Cellectis SA belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Cellectis SA (CLLS) current stock price?
As of the latest data, Cellectis SA stock price is $2.59, with a previous close of $2.63. Cellectis SA lost -$0.04 in the last trading session, representing a -1.52% loss.
What is Cellectis SA (CLLS) current market capitalization?
Cellectis SA market cap is approximately 188.06 million.
What is Cellectis SA (CLLS) Earnings Per Share (EPS)?
The trailing EPS is -$0.67, and the forward EPS is -$0.89.
What is Cellectis SA (CLLS) EBITDA?
Cellectis SA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -22.55 million.
Does Cellectis SA (CLLS) pay dividends?
No. Cellectis SA does not pay a dividend.
How did Cellectis SA (CLLS) perform in its most recent earnings report?
In the last report (March 31, 2026), Cellectis SA posted an EPS surprise of 30.77% and a revenue surprise of -38.13%.
When is Cellectis SA (CLLS) next earnings report?
Cellectis SA is expected to release its next earnings report on June 30, 2026.
What is Cellectis SA (CLLS) beta (volatility) score?
Cellectis SA has a beta of 2.747, indicating very high volatility compared to the market.
